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A B S T R A C T
Background: We had the opportunity to perform echocardiographic screening of children at local
community events for children’s healthcare sponsored by the prefectural government. The aim of this
study was to assess the utility of echocardiographic screening by measuring the prevalence of
congenital heart disease (CHD) and abnormal ﬁndings in children without history of diagnosed CHD.
Methods: Subjects consisted of 8819 infants and preschool children (1 month to 6 years) who underwent
echocardiographic examination at public events from 2001 to 2013. Children with known CHD were
excluded.
Results: We performed echocardiographic screening on 752 (range: 464–993) children at each event. At
a total of 12 events, subjects consisted of 3175 infants less than one year (36%), 2292 one-year-olds
(26%), 1058 two-year-olds (12%), 794 three-year-olds (9%), and other children up to age six years. We
identiﬁed echocardiographic abnormalities in 137 children (15.5/1000 subjects), and 89 children (10.1/
1000 subjects) were diagnosed with CHD. The prevalence of an echocardiographic abnormality did not
change over the 12-year period (Kendall’s tau = 0.272, p = 0.19).
Conclusions: CHD which could not be identiﬁed by prenatal echocardiography and neonatal auscultation
could be detected in a substantial number of young children by echocardiographic screening.
Echocardiographic screening may be useful for early diagnosis of CHD. However, our study is based on
cross-sectional data without follow-up. Larger prospective studies are needed to verify the utility of
echocardiographic screening with follow-up data in this cohort.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Congenital heart disease (CHD) forms the largest group of
congenital malformations [1]. Many prevalence studies of CHD
showed a wide range of incidences, from about 4 to 50 per
1000 subjects [2–8]. Reasons for the wide range of CHD prevalence
included differing diagnostic tools used in each study, population,
region, age, and observation period. Most previous studies
assessed the prevalence of CHD in a hospital.* Corresponding author at: Department of Cardiovascular Medicine, Tokushima
University Hospital, 2-50-1 Kuramoto, Tokushima 770-8503, Japan.
Tel.: +81 88 633 9311; fax: +81 88 633 7798.
E-mail address: kusunosek@tokushima-u.ac.jp (K. Kusunose).
http://dx.doi.org/10.1016/j.jjcc.2014.11.011
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsIn Japan, prenatal echocardiography has been performed for
early prenatal diagnosis of major CHD. After that, cardiac screening
of neonates and infants is usually performed by auscultation.
Medical check-ups in young children are required at 3–4 months,
18 months, and 3 years after birth in Japan, and the compliance rate
for undergoing the health examinations is 92–95% (reports from
Ministry of Health, Labour and Welfare, Japan). Even with the high
rate of these physical examinations, CHD can be diagnosed initially
in school age children or adulthood, sometimes in an advanced
stage. Prenatal echocardiographic images can be technically
difﬁcult to obtain because of the small and narrow window.
Screening echocardiography may provide additional information
in children who could not be identiﬁed by prenatal echocardiog-
raphy and neonatal auscultation. reserved.
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ing for infants and preschool children in annual community events
sponsored by the Tokushima prefectural government. The aim of
this study was to assess the utility of echocardiographic screening
by measuring the prevalence of CHD in children without history of
diagnosed CHD.
Methods
Study population
A cohort screening study was conducted from the data collected
in community healthcare events for children named ‘‘Ogyatto
21 Tokushima’’ between 2001 and 2013, which was organized by
the Hagukumi Tokushima Foundation, partially sponsored by the
Tokushima prefectural government (Fig. 1). This community event
began in May 2001 aiming to improve the health and well being of
infants and preschool children (6 years). The event occurred
2 days in every year except 2009, when there was a novel inﬂuenza
epidemic. The health event was free for everyone to attend. A
section of echocardiographic examination was held in conjunction
with this event. Children previously diagnosed with any CHD,
according to the medical interview, were excluded. In this cohort,
the data obtained from the records included age, gender, and
clinical diagnosis. This prefecture has a population of about
0.78 million people, and the average number of neonates born in
2012 was 7.4 per 1000.
Echocardiographic assessment
The echocardiographic examinations were performed with
either the Toshiba Aplio (Toshiba Medical Systems Inc., Tochigi,
Japan) or the GE Vivid 7 or E9 (General Electric Medical Systems,
Milwaukee, WI, USA) with a 7-MHz transducer. The examinationFig. 1. Snapshots from the community event ‘‘Ogyatto 21 Tokushima’’ for children’s health
visitors was around 9000. (B) Echocardiographic examination was performed by 
Cardiovascular Sonographers. (C) A pediatric cardiologist reviewed the images and conprotocol included two-dimensional and color Doppler imaging
from the parasternal, suprasternal, subxiphoid, apical, and, when
necessary, modiﬁed views. CHD is deﬁned as a structural
abnormality of the heart or intra-thoracic great vessels with
functional signiﬁcance or which has the potential to be signiﬁcant
[9]. We deﬁned other abnormalities as a valve regurgitation, valve
prolapse, coronary sinus dilatation, arrhythmia, left ventricular
(LV) hypertrophy, LV dilatation, and septal aneurysm. Atrial septal
defect (ASD) is assumed when the left atrial (LA) to right atrial (RA)
shunt ﬂow is recognized, with a defect size more than 3 mm.
Patent ductus arteriosus (PDA) and ventricular septal defect (VSD)
are assumed when there is left to right shunt ﬂow in the pulmonary
artery and right ventricle. Signiﬁcant valve stenosis was deﬁned
as the peak systolic velocity more than 2.5 m/s, and signiﬁcant
valve regurgitation was deﬁned as more than mild grade in mitral
and tricuspid regurgitation, equal to or more than mild grade in
aortic regurgitation. Each echocardiographic examination was
performed by experienced sonographers certiﬁed as Japanese
Registered Medical Sonographers. After the echocardiographic
examination, a pediatric cardiologist reviewed the images and
conﬁrmed the diagnosis, and a short medical interview was done
on site. Sedation was not required for any case. The mean time
required for the echocardiographic examination was 2 min.
Statistical analysis
Data are presented as mean  SD. The prevalence of CHD was
based on the number of CHD cases divided by the total number of
children who came to the events. The Chi-square test was used to
compare differences between the rates, and the Student’s t-test was
used to compare differences between the means. To eliminate the
impact of non-normal distribution, we correlated the prevalence of
echocardiographic abnormality, the age distribution, and time using
the Kendall tau rank correlation coefﬁcient. A p-value of <0.05 wascare in Tokushima Prefecture. (A) Overview of the community event. The number of
experienced licensed sonographers certiﬁed as Japanese Registered Diagnostic
ﬁrmed the diagnosis. A short medical interview was done on the site.
Fig. 2. Age distribution of the screening cohort. Subjects consisted of 3175 infants
aged less than one year (36%), 2292 one-year-olds (26%), 1058 two-year-olds (12%),
794 three-year-olds (9%), and other children up to age 6 years (17%).
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SPSS statistical package version 20.0 (SPSS Inc., Chicago, IL, USA).
Results
A total of 8819 children with no history of diagnosed CHD had a
screening echocardiography between 2001 and 2013, with the
exception of 2009. There was no overlap of participants in each
yearly event due to the prior notiﬁcation that this echocardiogram0
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Table 1
Age distribution in the most recent 5 years.
Year <1 y.o. (%) 1 y.o. (%) 2 y.o. (%) 
2008 41.2 20.8 11.4 
2010 36.4 20.2 13.2 
2011 37.8 23.8 12.8 
2012 34.2 23.2 12.9 
2013 37.9 24.8 13.1 
p-value for the trend 0.46 0.22 0.46 
y.o., year(s) old.should be done only for children without CHD history. We have
also excluded children who previously underwent screening
echocardiography by an interview. Of a total of 12 events, subjects
consisted of 3175 infants less than one year (36%), 2292 one-year-
olds (26%), 1058 two-year-olds (12%), 794 three-year-olds (9%),
and other children up to age 6 years (17%) (Fig. 2). The age range
was between 0 and 6 years with a median age of 1.6 years.
In all subjects at 12 events, we performed echocardiographic
screening on 752 (range: 464–993) children at each event. We
identiﬁed an echocardiographic abnormality in 137 children
(15.53 per 1000 subjects). The prevalence of echocardiographic
abnormality did not signiﬁcantly change over the 12-year period
(Kendall’s tau = 0.272, p = 0.19, Fig. 3). Table 1 shows the age
distribution in each year in the most recent 5 years. There is no
trend in the changes of age distribution.
Eighty-nine children (10.1/1000 subjects) were diagnosed
with CHD, which included 31 ASD (22.5%, 3.52 per 1000 subjects),
21 PDA (15.2%, 2.38 per 1000 subjects), 8 VSD (5.8%, 0.91 per
1000 subjects), 8 pulmonary artery stenosis (5.8%, 0.91 per
1000 subjects), and 7 pulmonary valve stenosis (5.1% and
0.79 per 1000 subjects) (Table 2). The prevalence of CHD in
children less than one year was higher than in 1- to 6-year-olds
(p < 0.001, Fig. 4). An example of a serious case was a one-
month-old boy with Bland-White-Garland syndrome which was
detected by signiﬁcant mitral regurgitation and severe left
ventricular dysfunction. It was the most serious case in this
study, and he was admitted to a hospital the next day for
treatment. In addition, clinical follow-up was available in
19 patients (61%) with ASD and 6 patients (29%) with PDA at
Tokushima Municipal Hospital. At the time of follow up,
6 patients with ASD and 3 patients with PDA were transferred0
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3 y.o. (%) 4 y.o. (%) 5 y.o. (%) 6 y.o. (%)
6.4 7.0 7.1 6.1
9.6 7.4 7.9 5.3
7.1 7.5 5.8 5.2
9.5 6.6 6.6 7.0
8.0 6.9 5.2 4.1
0.81 0.46 0.09 0.22
Table 2
Number of children with congenital heart disease or other abnormalities.
n % Prevalence/1000 Hoffman & Kaplan*
Prevalence IQR
Congenital heart disease
Atrial septal defect 31 22.5 3.52 0.37–1.06
Patent ductus arteriosus 21 15.2 2.38 0.4–0.8
Ventricular septal defect 8 5.8 0.91 1.76–4.48
Pulmonary stenosis 8 5.8 0.91 0.76–1.47
Pulmonary valve stenosis 7 5.1 0.79 0.36–0.84
Aortic bicuspid valve 5 3.6 0.57 5.34–13.8
Quadricuspid valve 2 1.4 0.23 –
Bland-White-Garland syndrome 1 0.7 0.11 –
Coronary-pulmonary artery ﬁstulae 2 1.4 0.23 –
AVSD 1 0.7 0.11 0.24–0.40
Left ventricular-right atrial communication 1 0.7 0.11 –
Supravalvular aortic stenosis 1 0.7 0.11 0.16–0.39
Cor triatriatum 1 0.7 0.11 –
Sub total 89 67.2 10.10
Other abnormality
Mitral prolapse 5 3.6 0.57 –
Mitral regurgitation 3 2.1 0.34
Aortic regurgitation 9 6.6 1.02 –
Tricuspid regurgitation 6 4.3 0.68 –
Coronary sinus dilatation 7 6.6 1.02
Arrhythmia (VPC) 5 3.6 0.57 –
LV hypertrophy 4 2.9 0.45 –
Atrium septal aneurysm 4 2.6 0.45 –
Ventricular septal aneurysm 3 2.1 0.34 –
Dextrocardia (inverted normal) 1 0.7 0.11
LV dilatation 1 0.7 0.11 –
Sub total 48 32.8 5.44
Total 137 100 15.54
IQR, interquartile range; LV, left ventricular; AVSD, atrioventricular septal defects; VPC, ventricular premature contraction.
* Adapted from Hoffman and Kaplan [3].
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had a role in detecting serious CHD compared with only a
physical examination due to the short time required for this
echocardiographic examination (the mean time was 2 min).
Discussion
This is the ﬁrst report evaluating the prevalence of CHD using
echocardiographic screening in a large number of children without
history of diagnosed CHD in Japan. Our main ﬁndings are as
follows. 1) Several echocardiographic abnormalities were detected
in 137 children, and there was no signiﬁcant time-trend in the
prevalence of echocardiographic abnormality from 2001 to 2013.
2) Eighty-nine children (10.1/1000 subjects) were diagnosed withp <0.001
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(per 1000)
0.0
5.0
10.0
15.0
20.0
25.0
0 1 2 3 4 5 6 years old
Fig. 4. Comparison of prevalence of congenital heart disease (CHD) between
children less than one year and 1-year-olds. There is a signiﬁcant difference
between the two groups (p < 0.001).CHD. The most common CHD abnormality was ASD, which
occurred in 3.5 per 1000 subjects, followed by PDA (2.4 per
1000) and VSD (1 per 1000). The prevalence of CHD in the less than
one-year-old group was higher than that in the older groups.
Recently, prenatal echocardiography has allowed for early
detection of CHD and may help to increase the number of
incidental ﬁndings. However, prenatal echocardiography mainly
helps to diagnose severe, major heart anatomical abnormalities,
such as tetralogy of Fallot. Therefore, even when prenatal
echocardiography is widely used, screening echocardiography in
this population has the potential to identify echocardiographic
abnormalities in infants and preschool children. From these
echocardiographic abnormal cases, we found 68% CHD. Even if
we exclude the minor echocardiographic abnormalities, the
number of CHD remains large (10.1/1000 subjects).
In our cohort without history of diagnosed CHD, the most
common subtype of CHD was ASD, which occurred in 3.5 per
1000 subjects. In addition, we also showed the prevalence of PDA
to be 2.4 per 1000 subjects. We were able to detect silent PDA in
this screening, which is a tiny arterial duct and is undetected by
auscultation [10]. On the other hand, the prevalence of VSD
in children without history of diagnosed CHD was 0.91 per
1000 children and relatively small compared with ASD and PDA.
One possible explanation is that our cohort was a speciﬁc
population who could not be identiﬁed by prenatal echocardiog-
raphy and neonatal auscultation. VSD causes a pathognomonic
pansystolic murmur. Auscultation is generally considered to be
sufﬁcient for detecting a signiﬁcant VSD.
The prevalence of CHD in the less than one-year-old group was
higher than in the older groups. One simple explanation is that
we avoid overlap examinations in our cohort. The other possible
explanation could be that the some ASD will naturally close before
pre-school, and the number may be overestimated [11]. However,
in several studies, the wide ranges (4–70%) of spontaneous closure
S. Nishio et al. / Journal of Cardiology 66 (2015) 315–319 319of ASD were reported [12,13]. In addition, Tortoriello et al. reported
that small ASD (defect 3–4 mm) enlarged to 24 mm after 6 years
[14]. If the defects remained open, they sometimes may become
problematic. In available follow-up data, some patients with ASD
or PDA were transferred to the surgical section. Historical cohorts
suggest long-term right heart failure, functional decline, arrhyth-
mia, and early death [15]. Our screening may help to detect these
subjects who need follow-up echocardiographic examination. We
believe that it can serve as an impetus for a properly designed
follow-up study.
In addition, we found a serious case of Bland-White-Garland
syndrome in this screening. In this case, poor weight gain had been
noted, but there was no murmur in the one-month regular
screening physical examination. Bland-White-Garland syndrome
is a rare congenital coronary artery anomaly and is considered
one of the most serious of anomalies. Thus, in spite of the high
rate of screening physical examinations in Japan, there is a
possibility of missing some diagnoses of severe heart disease.
Therefore, echocardiographic screening may help to detect these
severe heart defects. Despite expert prenatal echocardiography
and auscultation examination, CHD can be found in school age
children or adulthood, sometimes in an advanced stage. In children
with no history of diagnosed CHD, there is a relatively high
prevalence of echocardiographic abnormality (15.7/1000 subjects)
and CHD (10.1/1000 subjects) by screening echocardiography.
Our main limitation was that we were unable to obtain detailed
characteristics and follow-up data in this cohort. There is no
follow-up system in this event. We believe that a follow-up system
will be provided in future. This was a community-based transverse
study that only included children without history of diagnosed
CHD who were taken to this event by their parent. There is a
possibility that many of the children had parents with high health
awareness. There may be potential selection and referral biases.
Despite an otherwise standardized protocol, minor variations in
image quality were observed by reporting sonographers and
pediatric cardiologists. We may underestimate the prevalence of
CHD because of the limited time and views of echocardiography.
Some defects (VSD and ASD) we noticed in our study may close
naturally in the future and diagnosing them as CHD would be
unnecessary at that time; however, we believe it is important to
detect such defects that have some possibility to persist and have
signiﬁcant implications when they are older. We did not perform a
cost-beneﬁt analysis because of the limited data. Sonographers and
physicians joined this event as volunteers, and the echocardio-
graphic machines were freely provided by the vendors. Finally,
participants at these events did not include all children in
Tokushima city (ex. 2006: participants/all children = 993/2321,
42.8%). We believe larger studies with follow-up data are
warranted.
Conclusions
CHD which was not recognized by prenatal echocardiography
and neonatal auscultation could be identiﬁed in substantial
numbers by echocardiographic screening. Echocardiographic
screening in infants and preschool children in the community
may be useful for early diagnosis of CHD. Because our study isbased on a retrospective group without follow-up data, we believe
prospective studies with follow-up data are warranted to conﬁrm
this result.
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